{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:41:54Z","timestamp":1784950914826,"version":"3.55.0"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117544","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:06:03Z","timestamp":1763629563000},"page":"117544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["GPCRs in traumatic brain or spinal injury"],"prefix":"10.1016","volume":"243","author":[{"given":"Elaheh","family":"Zafarvahedian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Khosrojerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Seyedabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117544_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12987-022-00356-6","article-title":"Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis","volume":"19","author":"Zhang","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.bcp.2025.117544_b0010","article-title":"The time-dependent changes in a mouse model of traumatic brain injury with motor dysfunction","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117544_b0015","doi-asserted-by":"crossref","first-page":"D356","DOI":"10.1093\/nar\/gkv1178","article-title":"GPCRdb: an information system for G protein-coupled receptors","volume":"44","author":"Isberg","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117544_b0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117544_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2019.05.006","article-title":"Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR\/transducer selectivity and therapeutic potential","volume":"200","author":"Seyedabadi","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.bcp.2025.117544_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110167","article-title":"Flavors of GPCR signaling bias","volume":"261","author":"Seyedabadi","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117544_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020218","article-title":"Receptor-arrestin interactions: the GPCR perspective","volume":"11","author":"Seyedabadi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117544_b0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","article-title":"Recent advances in pathophysiology of traumatic brain injury","volume":"16","author":"Kaur","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-023-01477-6","article-title":"Spinal cord injury: molecular mechanisms and therapeutic interventions","volume":"8","author":"Hu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bcp.2025.117544_b0055","first-page":"1139","article-title":"Cellular and molecular pathophysiology of traumatic brain injury: what have we learned so far?","volume":"12","author":"Freire","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bcp.2025.117544_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105874","article-title":"The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies","volume":"180","author":"Zima","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2025.117544_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2021.10.029","article-title":"Central nervous system regeneration","volume":"185","author":"Varadarajan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117544_b0070","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11065-021-09524-1","article-title":"The relationship between cognitive functioning and symptoms of depression, anxiety, and post-traumatic stress disorder in adults with a traumatic brain injury: a meta-analysis","volume":"32","author":"Uiterwijk","year":"2022","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.bcp.2025.117544_b0075","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.tips.2017.09.004","article-title":"Temporal bias: time-encoded dynamic GPCR signaling","volume":"38","author":"Grundmann","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117544_b0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1098-1128(200003)20:2<103::AID-MED1>3.0.CO;2-X","article-title":"A3 adenosine receptor ligands: history and perspectives","volume":"20","author":"Baraldi","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.117544_b0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117544_b0090","article-title":"Effect of dipyridamole injected for myocardial perfusion imaging on blood glucose concentration; a preliminary study","volume":"10","author":"Khorasanchi","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.bcp.2025.117544_b0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00007632-199901150-00006","article-title":"A study of adenosine treatment in experimental acute spinal cord injury: effect on arachidonic acid metabolites","volume":"24","author":"Akpek","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.bcp.2025.117544_b0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728214.12.3.479","article-title":"Emerging adenosine receptor agonists","volume":"12","author":"Gao","year":"2007","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bcp.2025.117544_b0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.300.6.711","article-title":"Prevalence of chronic pain after traumatic brain injury: a systematic review","volume":"300","author":"Nampiaparampil","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2025.117544_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0301-0082(03)00050-9","article-title":"Adenosine in the spinal cord and periphery: release and regulation of pain","volume":"69","author":"Sawynok","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117544_b0115","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2174\/138161208784480090","article-title":"Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders","volume":"14","author":"Cunha","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2025.117544_b1250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0006-8993(99)02333-1","article-title":"Adenosine release upon spinal cord injury","volume":"854","author":"McAdoo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(02)03161-X","article-title":"Administration of adenosine receptor agonists or antagonists after controlled cortical impact in mice: effects on function and histopathology","volume":"951","author":"Varma","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b1255","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1440-1681.2002.03750.x","article-title":"Actions of specific adenosine receptor A1 and A2 agonists and antagonists in recovery of phrenic motor output following upper cervical spinal cord injury in adult rats","volume":"29","author":"Nantwi","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2025.117544_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-31","article-title":"Selective adenosine a 2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects","volume":"8","author":"Paterniti","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117544_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine a 3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117544_b0225","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s13311-021-01113-7","article-title":"Neuroprotective roles of the adenosine A3 receptor agonist AST-004 in mouse model of traumatic brain injury","volume":"18","author":"Bozdemir","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2025.117544_b0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-0186(02)00157-2","article-title":"Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain","volume":"42","author":"Beraudi","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2025.117544_b0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(00)00033-3","article-title":"Adenosine: does it have a neuroprotective role after all?","volume":"33","author":"De Mendon\u00e7a","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bcp.2025.117544_b0130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/neu.2009.1075","article-title":"Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice","volume":"27","author":"Haselkorn","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.jcbfm.9600218","article-title":"Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury","volume":"26","author":"Kochanek","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2025.117544_b0145","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00000542-200206000-00025","article-title":"Role of adenosine receptors in spinal G-protein activation after peripheral nerve injury","volume":"96","author":"Bantel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bcp.2025.117544_b0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sc.2009.194","article-title":"Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats","volume":"48","author":"Horiuchi","year":"2010","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bcp.2025.117544_b0155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bja.2024.01.005","article-title":"Enhancing spinal cord stimulation-induced pain inhibition by augmenting endogenous adenosine signalling after nerve injury in rats","volume":"132","author":"Cui","year":"2024","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bcp.2025.117544_b0160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2025.117544_b0165","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","article-title":"Tissue distribution of adenosine receptor mRNAs in the rat","volume":"118","author":"Dixon","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0170","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-4159.2007.05191.x","article-title":"Local stimulation of the adenosine A2B receptors induces an increased release of IL\u20106 in mouse striatum: an in vivo microdialysis study","volume":"105","author":"Vazquez","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117544_b0175","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1038\/tp.2017.98","article-title":"Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation","volume":"7","author":"Zhao","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117544_b0180","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1523\/JNEUROSCI.0268-10.2010","article-title":"Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury","volume":"30","author":"Dai","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0185","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1471-4159.2010.06716.x","article-title":"Adenosine A2A receptors in both bone marrow cells and non\u2010bone marrow cells contribute to traumatic brain injury","volume":"113","author":"Dai","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117544_b0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2459\/JCM.0b013e3282eee836","article-title":"Early adenosine receptor activation ameliorates spinal cord reperfusion injury","volume":"9","author":"Reece","year":"2008","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1067\/msy.2001.115838","article-title":"Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion","volume":"130","author":"Cassada","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.bcp.2025.117544_b0205","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/j.wneu.2019.01.164","article-title":"Time-dependent bidirectional neuroprotection by adenosine 2A receptor in experimental traumatic brain injury","volume":"125","author":"Velayutham","year":"2019","journal-title":"World Neurosurg."},{"key":"10.1016\/j.bcp.2025.117544_b0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2008.08.002","article-title":"Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage","volume":"596","author":"Bj\u00f6rklund","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0215","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bcp.2007.06.003","article-title":"Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen\u2013glucose deprivation episodes of different duration","volume":"74","author":"Pugliese","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbi.2017.10.021","article-title":"Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization","volume":"68","author":"Braun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117544_b0235","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","article-title":"Endocannabinoids and traumatic brain injury","volume":"163","author":"Shohami","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0240","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1080\/02699052.2021.1978548","article-title":"The changing landscape of the use of medical marijuana after traumatic brain injury: a narrative review","volume":"35","author":"Saulino","year":"2021","journal-title":"Brain Inj."},{"key":"10.1016\/j.bcp.2025.117544_b0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","article-title":"Cannabinoids and brain injury: therapeutic implications","volume":"8","author":"Mechoulam","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136855","article-title":"Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats","volume":"788","author":"Baron-Flores","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282920","article-title":"Combined non-psychoactive Cannabis components cannabidiol and \u03b2-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model","volume":"18","author":"Eeswara","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117544_b0260","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/neu.2010.1652","article-title":"Spinal cord injuries induce changes in CB1 cannabinoid receptor and CC chemokine expression in brain areas underlying circuitry of chronic pain conditions","volume":"28","author":"Knerlich-Lukoschus","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1682\/JRRD.2008.04.0049","article-title":"Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain","volume":"46","author":"Hama","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.bcp.2025.117544_b0270","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(00)00653-1","article-title":"2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-\u03b1 production in murine macrophages, and in mice","volume":"406","author":"Gallily","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0275","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3724\/abbs.2024183","article-title":"Cannabidiol alleviates the inflammatory response in rats with traumatic brain injury through the PGE 2-EP2-cAMP-PKA signaling pathway: CBD reduces inflammation caused by TBI","volume":"57","author":"Cao","year":"2025","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.bcp.2025.117544_b0300","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1527-3458.2003.tb00259.x","article-title":"BAY 38\u20137271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury","volume":"9","author":"Mauler","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.bcp.2025.117544_b0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/acn3.163","article-title":"Cannabinoid agonist rescues learning and memory after a traumatic brain injury","volume":"2","author":"Arain","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2015.04.016","article-title":"CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: a possible mechanism of improved recovery","volume":"597","author":"Hong","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0032-1304815","article-title":"KN38- Study Group, Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1\/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial","volume":"73","author":"Firsching","year":"2012","journal-title":"J. Neurol. Surg. Part A Cen. Eur. Neurosurg."},{"key":"10.1016\/j.bcp.2025.117544_b0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2017.06.020","article-title":"The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH\/Siah1 in a CB2-receptor dependent manner","volume":"1671","author":"Su","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-014-0191-6","article-title":"Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury","volume":"11","author":"Amenta","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117544_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113899","article-title":"Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury","volume":"347","author":"Li","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0325","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jnr.23114","article-title":"A cannabinoid type 2 receptor agonist attenuates blood\u2013brain barrier damage and neurodegeneration in a murine model of traumatic brain injury","volume":"90","author":"Amenta","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bcp.2025.117544_b0315","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1089\/neu.2011.1853","article-title":"Modulation of inflammatory responses by a cannabinoid-2\u2013selective agonist after spinal cord injury","volume":"28","author":"Adhikary","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0340","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/neur.2020.0059","article-title":"Delayed systemic treatment with cannabinoid receptor 2 agonist mitigates spinal cord injury-induced osteoporosis more than acute treatment directly after injury","volume":"2","author":"Tucci","year":"2021","journal-title":"Neurotrauma Rep."},{"key":"10.1016\/j.bcp.2025.117544_b0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.302.1.359","article-title":"Characterization of the diarylether sulfonylester (\u2212)-(R)-3-(2-hydroxymethylindanyl-4-oxy) phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties","volume":"302","author":"Mauler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b0295","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(03)03376-6","article-title":"Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271","volume":"989","author":"Mauler","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0345","doi-asserted-by":"crossref","first-page":"16196","DOI":"10.1038\/s41598-019-51720-w","article-title":"Bone anabolic response in the calvaria following mild traumatic brain injury is mediated by the cannabinoid-1 receptor","volume":"9","author":"Eger","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117544_b0350","doi-asserted-by":"crossref","unstructured":"F. Bachelerie, A. Ben-Baruch, A.M. Burkhardt, C. Combadiere, J.M. Farber, G.J. Graham, R. Horuk, A.H. Sparre-Ulrich, M. Locati, A.D. Luster, A. Mantovani, K. Matsushima, P.M. Murphy, R. Nibbs, H. Nomiyama, C.A. Power, A.E.I. Proudfoot, M.M. Rosenkilde, A. Rot, S. Sozzani, M. Thelen, O. Yoshie, A. Zlotnik, International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors, Pharmacological Reviews 66 (2014) 1\u201379. https:\/\/doi.org\/10.1124\/pr.113.007724.","DOI":"10.1124\/pr.113.007724"},{"key":"10.1016\/j.bcp.2025.117544_b0355","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2018.03.033","article-title":"Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury","volume":"71","author":"Puntambekar","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117544_b0365","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s43440-020-00187-y","article-title":"Traumatic brain injury in mice induces changes in the expression of the XCL1\/XCR1 and XCL1\/ITGA9 axes","volume":"72","author":"Ciechanowska","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2025.117544_b0370","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2015.04.003","article-title":"Inflammatory reaction after traumatic brain injury: Therapeutic potential of targeting cell-cell communication by chemokines","volume":"36","author":"Gyoneva","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117544_b0375","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917730212","article-title":"The chemokine receptor CXCR2 supports nociceptive sensitization after traumatic brain injury","volume":"13","author":"Liang","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bcp.2025.117544_b0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12974-016-0547-1","article-title":"Age exacerbates the CCR2\/5-mediated neuroinflammatory response to traumatic brain injury","volume":"13","author":"Morganti","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117544_b0385","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0002-9440(10)65752-5","article-title":"Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats","volume":"153","author":"Galasso","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2025.117544_b0390","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1089\/neu.2020.7015","article-title":"Chemokine receptors CC chemokine receptor 5 and C-X-C motif chemokine receptor 4 are new therapeutic targets for brain recovery after traumatic brain injury","volume":"38","author":"Liraz-Zaltsman","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0395","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117544_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113604","article-title":"Pharmacological blockers of CCR5 and CXCR4 improve recovery after traumatic brain injury","volume":"338","author":"Friedman-Levi","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188305","article-title":"The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury","volume":"12","author":"Woodcock","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117544_b0455","first-page":"1654","article-title":"The mechanism of chemokine receptor ACKR2 in cognitive impairment in young rats with traumatic brain injury","volume":"15","author":"Quan","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bcp.2025.117544_b0425","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.WCB.0000133470.91843.72","article-title":"The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury","volume":"24","author":"Rancan","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2025.117544_b0430","first-page":"55","article-title":"Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage","volume":"57","author":"Gaetani","year":"2013","journal-title":"J. Neurosurg. Sci."},{"key":"10.1016\/j.bcp.2025.117544_b0440","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fnins.2019.00462","article-title":"Overexpression of CX3CR1 in adipose-derived stem cells promotes cell migration and functional recovery after experimental intracerebral hemorrhage","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154771","article-title":"CXCL12 promotes proliferation of radial glia like cells after traumatic brain injury in rats","volume":"125","author":"Mao","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2025.117544_b0420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41419-025-07501-7","article-title":"Genetic deletion of G protein-coupled receptor 56 aggravates traumatic brain injury through the microglial CCL3\/4\/5 upregulation targeted to CCR5","volume":"16","author":"Sha","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117544_b0405","doi-asserted-by":"crossref","first-page":"11980","DOI":"10.1523\/JNEUROSCI.2920-08.2008","article-title":"G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity","volume":"28","author":"Gamo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12929-024-01083-w","article-title":"CCL5 is essential for axonogenesis and neuronal restoration after brain injury","volume":"31","author":"Ho","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2025.117544_b0435","doi-asserted-by":"crossref","first-page":"9910","DOI":"10.1523\/JNEUROSCI.2114-11.2011","article-title":"Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo\/iNOS+ macrophages","volume":"31","author":"Donnelly","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0450","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.170.5.2279","article-title":"Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6","volume":"170","author":"Fra","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2025.117544_b0460","first-page":"55","article-title":"Dopamine: a parallel pathway for the modulation of spinal locomotor networks","volume":"8","author":"Sharples","year":"2014","journal-title":"Front Neural Circ."},{"key":"10.1016\/j.bcp.2025.117544_b0465","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/neu.2011.1966","article-title":"Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats","volume":"29","author":"Shin","year":"2012","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0470","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/00001756-200210280-00013","article-title":"Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex","volume":"13","author":"Yan","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2025.117544_b0475","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s002590000308","article-title":"Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPET study using 123 I-\u03b2-CIT and 123 I-IBZM","volume":"27","author":"Donnemiller","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0480","doi-asserted-by":"crossref","first-page":"504","DOI":"10.12965\/jer.1938316.158","article-title":"Treadmill exercise improves memory by up-regulating dopamine and down-regulating D2 dopamine receptor in traumatic brain injury rats","volume":"15","author":"Ko","year":"2019","journal-title":"J. Exer. Rehabil."},{"key":"10.1016\/j.bcp.2025.117544_b0485","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/brain\/awx357","article-title":"Dopaminergic abnormalities following traumatic brain injury","volume":"141","author":"Jenkins","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117544_b0490","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awz118","article-title":"Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury","volume":"142","author":"Fridman","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117544_b0495","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1113\/EP088537","article-title":"Prefrontal dopaminergic system and its role in working memory and cognition in spinal cord\u2010injured rats","volume":"105","author":"Kheyrkhah","year":"2020","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bcp.2025.117544_b0500","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/350750","article-title":"Full anatomical recovery of the dopaminergic system after a complete spinal cord injury in lampreys","volume":"2015","author":"Fern\u00e1ndez-L\u00f3pez","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.bcp.2025.117544_b0505","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1471-4159.2008.05840.x","article-title":"Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury","volume":"108","author":"Wagner","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117544_b0510","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.PHM.0000091982.33232.CB","article-title":"Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats","volume":"82","author":"Wilson","year":"2003","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.bcp.2025.117544_b0515","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/121.6.1155","article-title":"Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients","volume":"121","author":"McDowell","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117544_b0520","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/08830738060210100901","article-title":"dopamine agonist therapy in low-response children following traumatic brain injury","volume":"21","author":"Patrick","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0525","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/neu.2020.7284","article-title":"Spinal dopaminergic mechanisms regulating the micturition reflex in male rats with complete spinal cord injury","volume":"38","author":"Qiao","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0530","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/neu.2015.4232","article-title":"Chronic contusion spinal cord injury impairs ejaculatory reflexes in male rats: partial recovery by systemic infusions of dopamine D3 receptor agonist 7OHDPAT","volume":"33","author":"Kozyrev","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0535","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biomedicines9010047","article-title":"Quinpirole-mediated regulation of dopamine D2 receptors inhibits glial cell-induced neuroinflammation in cortex and striatum after brain injury","volume":"9","author":"Alam","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2025.117544_b0540","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1097\/BRS.0000000000001287","article-title":"Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord injury","volume":"41","author":"Jiang","year":"2016","journal-title":"Spine"},{"key":"10.1016\/j.bcp.2025.117544_b0545","article-title":"Pramipexole has a neuroprotective effect in spinal cord injury and upregulates D2 receptor expression in the injured spinal cord tissue in rats","volume":"11","author":"Liu","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bcp.2025.117544_b0550","doi-asserted-by":"crossref","first-page":"349","DOI":"10.37349\/ent.2024.00088","article-title":"Lysophospholipid receptors in neurodegeneration and neuroprotection","volume":"4","author":"Birgbauer","year":"2024","journal-title":"Explor. Neuroprotect. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b0595","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2014.07.010","article-title":"FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation","volume":"274","author":"Mencl","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2025.117544_b0610","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1448570","article-title":"Overexpression of endothelial S1pr2 promotes blood-brain barrier disruption via JNK\/c-Jun\/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models","volume":"15","author":"Cheng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0580","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7150\/ijms.49066","article-title":"FTY720 reduces endothelial cell apoptosis and remodels neurovascular unit after experimental traumatic brain injury","volume":"18","author":"Cheng","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bcp.2025.117544_b0570","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1089\/neu.2017.5391","article-title":"Sphingosine 1-phosphate receptor subtype 1 as a therapeutic target for brain trauma","volume":"35","author":"Cuzzocrea","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0575","doi-asserted-by":"crossref","unstructured":"X. Qu, Z. Zhang, X. Xu, J. Wang, C. Lei, G. Zhou, W. Wu, L. Huang, X. Chen, S. Yu, T. Wang, Selective sphingosine-1-phosphate receptor 1 modulation ameliorates TBI-induced neurological deficit after CCI., Neurosci Lett 750 (2021) 135748. https:\/\/doi.org\/10.1016\/j.neulet.2021.135748.","DOI":"10.1016\/j.neulet.2021.135748"},{"key":"10.1016\/j.bcp.2025.117544_b0600","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.4491-12.2013","article-title":"An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway","volume":"33","author":"Guo","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0670","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2020.00016","article-title":"Lysophosphatidic acid induces apoptosis of PC12 cells through LPA1 receptor\/LPA2 receptor\/MAPK signaling pathway","volume":"13","author":"Zhang","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1260","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0680","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbi.2018.12.007","article-title":"Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice","volume":"76","author":"L\u00f3pez-Serrano","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117544_b1265","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/j.pain.0000000000001019","article-title":"Nervous system delivery of antilysophosphatidic acid antibody by nasal application attenuates mechanical allodynia after traumatic brain injury in rats","volume":"158","author":"Eisenried","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2025.117544_b0555","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainresbull.2020.08.013","article-title":"FTY720 in CNS injuries: molecular mechanisms and therapeutic potential","volume":"164","author":"Zhang","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2025.117544_b0560","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14673","article-title":"CD4(+) CD11b(+) T cells infiltrate and aggravate the traumatic brain injury depending on brain-to-cervical lymph node signaling","volume":"30","author":"Jiang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b0565","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2006-0223","article-title":"Essential roles of sphingosine 1-phosphate\/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury","volume":"25","author":"Kimura","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcp.2025.117544_b0585","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1089\/neu.2019.6905","article-title":"FTY720 attenuates neuropathic pain after spinal cord injury by decreasing systemic and local inflammation in a rat spinal cord compression model","volume":"37","author":"Yamazaki","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0590","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1089\/neu.2019.6951","article-title":"Fingolimod attenuates lung injury and cardiac dysfunction after traumatic brain injury","volume":"37","author":"Qian","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0605","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8072156","article-title":"Activation of sphingosine 1-phosphate receptor 1 enhances hippocampus neurogenesis in a rat model of traumatic brain injury: an involvement of MEK\/Erk signaling pathway","volume":"2016","author":"Ye","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.bcp.2025.117544_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2024053225","article-title":"Transplantation of miR-193b-3p-transfected bmscs improves neurological impairment after traumatic brain injury through S1PR3-mediated regulation of the PI3K\/AKT\/mTOR signaling pathway","volume":"34","author":"He","year":"2024","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.bcp.2025.117544_b0620","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1476-5381.2012.02061.x","article-title":"The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate","volume":"167","author":"Gergely","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b0625","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0955-0674(95)80029-8","article-title":"Lysophosphatidic acid signalling","volume":"7","author":"Moolenaar","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117544_b0630","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets","volume":"291","author":"Eichholtz","year":"1993","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2025.117544_b0635","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.611816","article-title":"antibodies against lysophosphatidic acid protect against blast-induced ocular injuries","volume":"11","author":"Arun","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0640","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-11-37","article-title":"Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes","volume":"11","author":"Crack","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117544_b0645","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2023.0087","article-title":"Cerebrospinal fluid levels of lysophosphatidic acids can provide suitable biomarkers of blast-induced traumatic brain injury","author":"Arun","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0650","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ajpath.2018.05.005","article-title":"Matrix-assisted laser desorption ionization mapping of lysophosphatidic acid changes after traumatic brain injury and the relationship to cellular pathology","volume":"188","author":"McDonald","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2025.117544_b0655","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10571-011-9650-0","article-title":"Modulation of LPA receptor expression in the human brain following neurotrauma","volume":"31","author":"Frugier","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117544_b0660","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00441-010-0977-5","article-title":"LPA receptor expression in the central nervous system in health and following injury","volume":"341","author":"Goldshmit","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2025.117544_b0665","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0675","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12883-022-02694-2","article-title":"The LPA-CDK5-tau pathway mediates neuronal injury in an in vitro model of ischemia-reperfusion insult","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0685","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11011-014-9623-3","article-title":"Reduction in traumatic brain injury-induced oxidative stress, apoptosis, and calcium entry in rat hippocampus by melatonin: possible involvement of TRPM2 channels","volume":"30","author":"Y\u00fcr\u00fcker","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bcp.2025.117544_b0690","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5152\/eurasianjmed.2015.0267","article-title":"A review of melatonin, its receptors and drugs","volume":"48","author":"Emet","year":"2016","journal-title":"Euras. J. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0695","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2025.117544_b0700","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","article-title":"Melatonin membrane receptors in peripheral tissues: distribution and functions","volume":"351","author":"Slominski","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117544_b0705","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2017.03.053","article-title":"Brain injury results in lower levels of melatonin receptors subtypes MT1 and MT2","volume":"650","author":"Osier","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b0710","first-page":"2189","article-title":"Absence of detectable melatonin and preservation of cortisol and thyrotropin rhythms in tetraplegia","volume":"85","author":"Zeitzer","year":"2000","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bcp.2025.117544_b0715","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41393-024-00959-w","article-title":"Melatonin secretion and sleep disorders in patients with spinal cord injuries","volume":"62","author":"Hartley","year":"2024","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bcp.2025.117544_b0720","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.sc.3101784","article-title":"Reduced sleep efficiency in cervical spinal cord injury; association with abolished night time melatonin secretion","volume":"44","author":"Scheer","year":"2006","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bcp.2025.117544_b0725","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.arcmed.2013.04.002","article-title":"Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: role of oxidative stresses","volume":"44","author":"Dehghan","year":"2013","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bcp.2025.117544_b0730","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.25011\/cim.v43i4.34829","article-title":"Effect of melatonin on regeneration of cortical neurons in rats with traumatic brain injury","volume":"43","author":"Ge","year":"2020","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136754","article-title":"Melatonin mitigates traumatic brain injury-induced depression-like behaviors through HO-1\/CREB signal in rats","volume":"784","author":"Xie","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b0740","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2015.11.043","article-title":"Targeting different pathophysiological events after traumatic brain injury in mice: role of melatonin and memantine","volume":"612","author":"Kelestemur","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b0745","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2018.12.014","article-title":"Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway","volume":"131","author":"Wang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0750","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.apmr.2015.05.011","article-title":"Pilot Study on the effect of ramelteon on sleep disturbance after traumatic brain injury: preliminary evidence from a clinical trial","volume":"96","author":"Lequerica","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.bcp.2025.117544_b0755","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jnr.24409","article-title":"Melatonin improves functional recovery in female rats after acute spinal cord injury by modulating polarization of spinal microglial\/macrophages","volume":"97","author":"Zhang","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bcp.2025.117544_b0760","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s12031-014-0430-4","article-title":"Melatonin treatment protects against acute spinal cord injury-induced disruption of blood spinal cord barrier in mice","volume":"54","author":"Wu","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0765","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pain.2007.01.025","article-title":"Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors","volume":"132","author":"Ambriz-Tututi","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2025.117544_b0770","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/etm.2023.12325","article-title":"Melatonin exerts neuroprotective effects in mice with spinal cord injury by activating the Nrf2\/Keap1 signaling pathway via the MT2 receptor","volume":"27","author":"Yan","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0775","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12695","article-title":"Melatonin promotes regeneration of injured motor axons via MT1 receptors","volume":"70","author":"Stazi","year":"2021","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2025.117544_b0780","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-079X.2010.00751.x","article-title":"Synergistic effect of melatonin on exercise\u2010induced neuronal reconstruction and functional recovery in a spinal cord injury animal model","volume":"48","author":"Park","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2025.117544_b0785","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1440-1681.12216","article-title":"Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats","volume":"41","author":"Tavuk\u00e7u","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2025.117544_b0790","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-079X.2007.00454.x","article-title":"Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma","volume":"43","author":"Genovese","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2025.117544_b0795","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00586-003-0550-y","article-title":"Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury","volume":"13","author":"Cayli","year":"2004","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.bcp.2025.117544_b0800","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4615-0123-7_7","article-title":"Neuroprotective activity of metabotropic glutamate receptor ligands","volume":"513","author":"Flor","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2025.117544_b0805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mrdd.1033","article-title":"Traumatic brain injury: developmental differences in glutamate receptor response and the impact on treatment","volume":"7","author":"4th Lea","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bcp.2025.117544_b0810","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2202-8-96","article-title":"Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors","volume":"8","author":"Fei","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173452","article-title":"Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: Particular emphasis on the role of mGlu4 and mGlu7 receptors","volume":"219","author":"Domin","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bcp.2025.117544_b0820","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/00001756-199707280-00028","article-title":"mGluR modulation of post-traumatic neuronal death: role of NMDA receptors","volume":"8","author":"Mukhin","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2025.117544_b0825","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(95)01081-6","article-title":"Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats","volume":"700","author":"Gong","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0830","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exnr.2001.7643","article-title":"Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats","volume":"169","author":"Lyeth","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0835","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/089771504322972068","article-title":"Group I metabotropic receptor antagonism blocks depletion of calcium stores and reduces potentiated capacitative calcium entry in strain-injured neurons and astrocytes","volume":"21","author":"Chen","year":"2004","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0840","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41420-024-01916-5","article-title":"Preso enhances mGluR1-mediated excitotoxicity by modulating the phosphorylation of mGluR1-Homer1 complex and facilitating an ER stress after traumatic brain injury","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2025.117544_b0845","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3892\/ijmm.2011.870","article-title":"The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway","volume":"29","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117544_b0850","doi-asserted-by":"crossref","first-page":"e1174","DOI":"10.1038\/cddis.2014.116","article-title":"Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors","volume":"5","author":"Luo","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117544_b0855","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/neu.1999.16.893","article-title":"Metabotropic glutamate receptor protein alterations after traumatic brain injury in rats","volume":"16","author":"Gong","year":"1999","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0860","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/neu.2006.23.117","article-title":"Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury","volume":"23","author":"Movsesyan","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0870","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/neu.1997.14.885","article-title":"Neuroprotective effects of group III mGluR in traumatic neuronal injury","volume":"14","author":"Faden","year":"1997","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0865","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3565(24)34874-8","article-title":"Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury","volume":"290","author":"Allen","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b0875","doi-asserted-by":"crossref","first-page":"18598","DOI":"10.1523\/JNEUROSCI.3499-11.2011","article-title":"Adaptations in glutamate and glycine content within the lumbar spinal cord are associated with the generation of novel gait patterns in rats following neonatal spinal cord transection","volume":"31","author":"Cantoria","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0880","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41467-024-45300-4","article-title":"Functional plasticity of glutamatergic neurons of medullary reticular nuclei after spinal cord injury in mice","volume":"15","author":"Lemieux","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117544_b0885","doi-asserted-by":"crossref","first-page":"e1736","DOI":"10.1089\/neu.2023.0423","article-title":"Time-dependent long-term effect of memantine following repetitive mild traumatic brain injury","volume":"41","author":"Boucher","year":"2024","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2021.0063","article-title":"Endogenous opioid dynorphin is a potential link between traumatic brain injury, chronic pain, and substance use disorder","volume":"39","author":"Best","year":"2022","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b0895","article-title":"Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice","volume":"22","author":"Hamood","year":"2022","journal-title":"Brain, Behav., Immun. \u2013 Health"},{"key":"10.1016\/j.bcp.2025.117544_b0935","doi-asserted-by":"crossref","first-page":"R1527","DOI":"10.1152\/ajpregu.1991.261.6.R1527","article-title":"Kappa-opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury","volume":"261","author":"Vink","year":"1991","journal-title":"Am. J. Physiol.-Regul., Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2025.117544_b0920","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0333102418777507","article-title":"The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target","volume":"39","author":"Moye","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bcp.2025.117544_b0940","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cns.13655","article-title":"Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice","volume":"27","author":"Wang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b0925","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-8993(87)91599-X","article-title":"Beneficial effects of the \u03ba opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury","volume":"435","author":"Hall","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0950","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(93)90561-Z","article-title":"Effect of U-50488h, a selective opioid \u03ba receptor agonist, on vascular injury after spinal cord trauma","volume":"626","author":"Qu","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0955","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/cns.1987.4.227","article-title":"\u03ba-Selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats","volume":"4","author":"Faden","year":"1987","journal-title":"Cent. Nerv. Syst. Trauma"},{"key":"10.1016\/j.bcp.2025.117544_b0900","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbr.2017.03.015","article-title":"Naloxone exacerbates memory impairments and depressive-like behavior after mild traumatic brain injury (mTBI) in mice with upregulated opioid system activity","volume":"326","author":"Lesniak","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0905","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neuropharm.2015.10.014","article-title":"Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)","volume":"101","author":"Lesniak","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117544_b0910","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0143-4179(95)90051-9","article-title":"Effects of mu opioid agonist and antagonist on neurological outcome following traumatic brain injury in the rat","volume":"29","author":"Lyeth","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bcp.2025.117544_b0915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresbull.2021.08.010","article-title":"Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system","volume":"176","author":"Rahimi","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2025.117544_b0930","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(93)90614-S","article-title":"Combined scopolamine and morphine treatment of traumatic brain injury in the rat","volume":"617","author":"Lyeth","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b0945","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1523\/JNEUROSCI.10-11-03524.1990","article-title":"Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats","volume":"10","author":"Vink","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b0960","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sc.2016.28","article-title":"Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury","volume":"54","author":"Aceves","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bcp.2025.117544_b0965","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbi.2016.08.004","article-title":"Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury","volume":"58","author":"Ellis","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117544_b0970","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117544_b0975","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1165\/rcmb.2014-0084OC","article-title":"Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K\/nuclear factor-\u03baB-dependent manner in human pleural mesothelial cells","volume":"52","author":"Jeffers","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117544_b0980","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1160\/TH08-03-0131","article-title":"Prothrombin\/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases","volume":"100","author":"Sokolova","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2025.117544_b0985","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12035-021-02639-9","article-title":"Physical exercise as a modulator of vascular pathology and thrombin generation to improve outcomes after traumatic brain injury","volume":"59","author":"Papalia","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117544_b0990","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.expneurol.2013.02.011","article-title":"Thrombin regulation of synaptic plasticity: implications for physiology and pathology","volume":"247","author":"Maggio","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b0995","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040562","article-title":"Role of thrombin in central nervous system injury and disease","volume":"11","author":"Shlobin","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117544_b1000","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.STR.31.3.791-c","article-title":"Antithrombin therapy for intracerebral hemorrhage","volume":"31","author":"Hamada","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2025.117544_b1005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1471-4159.2003.01268.x","article-title":"The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?","volume":"84","author":"Xi","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117544_b1010","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1523\/JNEUROSCI.20-12-04582.2000","article-title":"Potentiation of NMDA receptor function by the serine protease thrombin","volume":"20","author":"Gingrich","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jnc.12075","article-title":"Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity","volume":"124","author":"Almonte","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117544_b1020","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1089\/neu.2015.4146","article-title":"Minimal traumatic brain injury in mice: protease-activated receptor 1 and thrombin-related changes","volume":"33","author":"Itsekson-Hayosh","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117544_b1025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2006.12.050","article-title":"Protease-activated receptor-1 induces generation of new microglia in the dentate gyrus of traumatised hippocampal slice cultures","volume":"415","author":"Laskowski","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117544_b1030","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3389\/fphar.2019.01532","article-title":"Thrombin as key mediator of seizure development following traumatic brain injury","volume":"10","author":"Ben Shimon","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b1035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0271678X17742792","article-title":"Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin","volume":"39","author":"Piao","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2025.117544_b1040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2016.04.071","article-title":"Membrane lipid peroxidation in neurodegeneration: role of thrombin and proteinase-activated receptor-1","volume":"1643","author":"Citron","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b1045","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1021\/acschemneuro.1c00557","article-title":"Discovery and optimization of a novel series of competitive and central nervous system-penetrant protease-activated receptor 4 (PAR4) inhibitors","volume":"12","author":"Bertron","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1050","doi-asserted-by":"crossref","unstructured":"A.A. El-Gazar, A.A. Soubh, D.M. Abdallah, G.M. Ragab, H.S. El-Abhar, Elucidating PAR1 as a therapeutic target for delayed traumatic brain injury: Unveiling the PPAR-\u03b3\/Nrf2\/HO-1\/GPX4 axis to suppress ferroptosis and alleviate NLRP3 inflammasome activation in rats., Int Immunopharmacol 139 (2024) 112774. https:\/\/doi.org\/10.1016\/j.intimp.2024.112774.","DOI":"10.1016\/j.intimp.2024.112774"},{"key":"10.1016\/j.bcp.2025.117544_b1055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12031-013-0200-8","article-title":"Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist","volume":"53","author":"Itzekson","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1070","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/glia.23215","article-title":"Protease activated receptor 2 controls myelin development, resiliency and repair","volume":"65","author":"Yoon","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117544_b1060","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4243953","article-title":"Mast cell activation, neuroinflammation, and tight junction protein derangement in acute traumatic brain injury","volume":"2020","author":"Kempuraj","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2025.117544_b1065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2015.08.021","article-title":"Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury","volume":"83","author":"Radulovic","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117544_b1075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12264-020-00601-8","article-title":"Antagonism of protease-activated receptor 4 protects against traumatic brain injury by suppressing neuroinflammation via inhibition of Tab2\/NF-\u03baB signaling","volume":"37","author":"Luo","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bcp.2025.117544_b1080","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1124\/jpet.107.133595","article-title":"Inhibiting protease-activated receptor 4 limits myocardial ischemia\/reperfusion injury in rat hearts by unmasking adenosine signaling","volume":"324","author":"Strande","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b1085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00395-019-0771-9","article-title":"Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart","volume":"115","author":"Fender","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2025.117544_b1090","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/bloodadvances.2018018283","article-title":"Hematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice","volume":"2","author":"Fran\u00e7ois","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcp.2025.117544_b1095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2022.01.074","article-title":"Blocking protease-activated receptor 4 alleviates liver injury induced by brain death","volume":"595","author":"Fang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.117544_b1100","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0956857d-ecf5-4fb7-a834-131915a38a6a","article-title":"Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets","volume":"8","author":"Arachiche","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117544_b1105","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2020.590299","article-title":"Serotonergic modulation of locomotor activity from basal vertebrates to mammals","volume":"14","author":"Flaive","year":"2020","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.bcp.2025.117544_b1110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","article-title":"The role of different serotonin receptor subtypes in seizure susceptibility","volume":"232","author":"Gharedaghi","year":"2014","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b1115","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1152\/jn.91179.2008","article-title":"Locomotor-activated neurons of the cat. I. Serotonergic innervation and co-localization of 5-HT7, 5-HT2A, and 5-HT1A receptors in the thoraco-lumbar spinal cord","volume":"102","author":"Noga","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2025.117544_b1120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/brainsci14010051","article-title":"Strain in the midbrain: impact of traumatic brain injury on the central serotonin system","volume":"14","author":"O\u2019Connell","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.bcp.2025.117544_b1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/2374-6890\/7\/1\/001142","article-title":"Serotonin 2A receptor autoantibodies increase in adult traumatic brain injury in association with neurodegeneration","volume":"7","author":"Zimering","year":"2020","journal-title":"J. Endocrinol. Diab."},{"key":"10.1016\/j.bcp.2025.117544_b1130","first-page":"1","article-title":"Repeated traumatic brain injury is associated with neurotoxic plasma autoantibodies directed against the Serotonin 2A and Alpha 1 adrenergic receptors","volume":"7","author":"Zimering","year":"2023","journal-title":"Endocrinol. Diab. Metab. J."},{"key":"10.1016\/j.bcp.2025.117544_b1135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.expneurol.2019.05.007","article-title":"Serotonergic mechanisms in spinal cord injury","volume":"318","author":"Perrin","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b1140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1113\/JP272271","article-title":"Serotonin controls initiation of locomotion and afferent modulation of coordination via 5-HT7 receptors in adult rats","volume":"595","author":"Cabaj","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117544_b1145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.expneurol.2013.02.008","article-title":"Grafting of fetal brainstem 5-HT neurons into the sublesional spinal cord of paraplegic rats restores coordinated hindlimb locomotion","volume":"247","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b1150","first-page":"95","article-title":"5-HT2 and 5-HT7 receptor agonists facilitate plantar stepping in chronic spinal rats through actions on different populations of spinal neurons","volume":"8","author":"S\u0142awi\u0144ska","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.bcp.2025.117544_b1155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1460-9568.2002.02088.x","article-title":"Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist","volume":"16","author":"Antri","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1160","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1460-9568.2008.06508.x","article-title":"Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection","volume":"28","author":"Ung","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/bne0000176","article-title":"Stimulation of 5-HT2A receptors recovers sensory responsiveness in acute spinal neonatal rats","volume":"131","author":"Swann","year":"2017","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.bcp.2025.117544_b1270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2009.10.003","article-title":"5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats","volume":"221","author":"Hayashi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b1275","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1152\/jn.00821.2012","article-title":"Constitutively active 5-HT2\/\u03b11 receptors facilitate muscle spasms after human spinal cord injury","volume":"109","author":"D\u2019Amico","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2025.117544_b1235","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1038\/s41467-021-27419-w","article-title":"An injury-induced serotonergic neuron subpopulation contributes to axon regrowth and function restoration after spinal cord injury in zebrafish","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117544_b1240","doi-asserted-by":"crossref","unstructured":"E.C. Simmons, N.E. Scholpa, R.G. Schnellmann, FDA-approved 5-HT(1F) receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury., Exp Neurol 341 (2021) 113720. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113720.","DOI":"10.1016\/j.expneurol.2021.113720"},{"key":"10.1016\/j.bcp.2025.117544_b1245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/jpet.119.262410","article-title":"5-hydroxytryptamine 1F receptor agonist induces mitochondrial biogenesis and promotes recovery from spinal cord injury","volume":"372","author":"Simmons","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117544_b1210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fncir.2020.00014","article-title":"Contribution of 5-HT2 receptors to the control of the spinal locomotor system in intact rats","volume":"14","author":"Majczy\u0144ski","year":"2020","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.bcp.2025.117544_b1280","article-title":"Circulating neurotoxic 5-HT2A receptor agonist autoantibodies in adult type 2 diabetes with Parkinson\u2019s disease","volume":"5","author":"Zimering","year":"2018","journal-title":"J. Endocrinol. Diab."},{"key":"10.1016\/j.bcp.2025.117544_b1285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bju.13964","article-title":"Chronic spinal cord injury causes upregulation of serotonin (5-HT)(2A) and 5-HT(2C) receptors in lumbosacral cord motoneurons","volume":"121","author":"Cao","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.bcp.2025.117544_b1175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/exnr.2001.7660","article-title":"The serotonergic 5-HT(2C) agonist m-chlorophenylpiperazine increases weight-supported locomotion without development of tolerance in rats with spinal transections","volume":"169","author":"Kim","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117544_b1225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pain.2003.12.019","article-title":"Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury","volume":"108","author":"Obata","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2025.117544_b1170","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrd3234","article-title":"Spinal cord injury: the two faces of spontaneous serotonin signalling","volume":"9","author":"Kingwell","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117544_b1180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1152\/jn.01011.2010","article-title":"Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors","volume":"106","author":"Murray","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2025.117544_b1185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9258(18)81366-7","article-title":"Aromatic l-amino acid decarboxylase","volume":"237","author":"Lovenberg","year":"1962","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117544_b1190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroscience.2012.12.063","article-title":"The time course of serotonin 2C receptor expression after spinal transection of rats: an immunohistochemical study","volume":"236","author":"Ren","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2025.117544_b1195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0028-3908(81)90216-1","article-title":"Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5, 7-dihydroxytryptamine injection","volume":"20","author":"Barbeau","year":"1981","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117544_b1200","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1152\/jn.00190.2017","article-title":"Constitutive activity of 5-HT(2C) receptors is present after incomplete spinal cord injury but is not modified after chronic SSRI or baclofen treatment","volume":"118","author":"Tysseling","year":"2017","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2025.117544_b1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.08.014","article-title":"Morphine-induced Straub tail reaction in mice treated with serotonergic compounds","volume":"791","author":"Belozertseva","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117544_b1215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00221-002-1352-x","article-title":"Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat","volume":"149","author":"Hains","year":"2003","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bcp.2025.117544_b1220","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuropharm.2012.04.034","article-title":"Potentiation of acid-sensing ion channel activity by the activation of 5-HT2 receptors in rat dorsal root ganglion neurons","volume":"63","author":"Qiu","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117544_b1230","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.celrep.2015.09.050","article-title":"Serotonin promotes development and regeneration of spinal motor neurons in zebrafish","volume":"13","author":"Barreiro-Iglesias","year":"2015","journal-title":"Cell Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:23:41Z","timestamp":1781065421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":257,"alternative-id":["S0006295225008093"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117544","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPCRs in traumatic brain or spinal injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117544"}}